Wells Fargo’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-97,784
| Closed | -$2.87M | – | 6719 |
|
|
2017
Q3 | $2.87M | Sell |
97,784
-254,936
| -72% | -$7.14M | ﹤0.01% | 2999 |
|
|
2017
Q2 | $9.26M | Buy |
352,720
+1,638
| +0.5% | +$40.3K | ﹤0.01% | 1975 |
|
|
2017
Q1 | $8.21M | Buy |
351,082
+12,187
| +4% | +$301K | ﹤0.01% | 2034 |
|
|
2016
Q4 | $8.52M | Sell |
338,895
-70,085
| -17% | -$1.77M | ﹤0.01% | 1970 |
|
|
2016
Q3 | $11.5M | Buy |
408,980
+100,556
| +33% | +$2.58M | ﹤0.01% | 1676 |
|
|
2016
Q2 | $7.61M | Sell |
308,424
-28,096
| -8% | -$697K | ﹤0.01% | 2019 |
|
|
2016
Q1 | $7.44M | Buy |
336,520
+31,046
| +10% | +$826K | ﹤0.01% | 2021 |
|
|
2015
Q4 | $10.7M | Buy |
305,474
+10,609
| +4% | +$332K | ﹤0.01% | 1787 |
|
|
2015
Q3 | $8.39M | Buy |
294,865
+32,940
| +13% | +$1.11M | ﹤0.01% | 1940 |
|
|
2015
Q2 | $8.72M | Buy |
261,925
+86,836
| +50% | +$2.67M | ﹤0.01% | 2008 |
|
|
2015
Q1 | $4.93M | Buy |
175,089
+30,755
| +21% | +$764K | ﹤0.01% | 2382 |
|
|
2014
Q4 | $2.99M | Sell |
144,334
-5,710
| -4% | -$136K | ﹤0.01% | 2727 |
|
|
2014
Q3 | $3.67M | Sell |
150,044
-60,621
| -29% | -$1.61M | ﹤0.01% | 2559 |
|
|
2014
Q2 | $6.02M | Buy |
210,665
+50,981
| +32% | +$1.42M | ﹤0.01% | 2194 |
|
|
2014
Q1 | $4.47M | Buy |
159,684
+66,423
| +71% | +$1.63M | ﹤0.01% | 2393 |
|
|
2013
Q4 | $2.01M | Buy |
93,261
+67,317
| +259% | +$1.22M | ﹤0.01% | 2944 |
|
|
2013
Q3 | $345K | Buy |
25,944
+3,079
| +13% | +$41.5K | ﹤0.01% | 3931 |
|
|
2013
Q2 | $317K | Buy |
+22,865
| New | +$324K | ﹤0.01% | 3899 |
|
Wells Fargo's PMC Position: Q4 2017 in Review
Wells Fargo sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 97,784 shares — an estimated $2.87M sold.
Wells Fargo first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $11.5M in Q3 2016. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Wells Fargo reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Wells Fargo sold 97,784 PharMerica Corporation shares in Q4 2017, an estimated $2.87M.
- Wells Fargo first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Wells Fargo's PharMerica Corporation position peaked at $11.5M in Q3 2016.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Wells Fargo's 13F filing for Q4 2017, filed 8 Feb 2018.